申请人:The Procter & Gamble Company
公开号:US20030109556A1
公开(公告)日:2003-06-12
Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula:
1
wherein A is a conformationally restricted ring system selected from the group consisting of:
a) non-aromatic carbocyclic rings;
b) aromatic carbocyclic rings;
c) non-aromatic heterocyclic rings;
d) aromatic heterocyclic rings;
wherein said rings comprises from 5 to 8 atoms; and W is a unit which preferable comprises D-1-fluorophenyalanine, Y comprises a heteroatom, and Z comprises an aromatic carbocyclic ring. Also disclosed are pharmaceutical compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 receptors.
本发明涉及MC-3/MC-4受体配体,该配体具有以下公式:1其中A是从以下组中选择的构象限制性环系统:a)非芳香碳环;b)芳香碳环;c)非芳香杂环;d)芳香杂环;其中所述环包含5至8个原子;W是一个单元,它更喜欢包含D-1-氟苯丙氨酸,Y包含一个杂原子,Z包含一个芳香碳环。本发明还涉及包含该配体的制药组合物,以及通过MC-3/MC-4受体介导的疾病的治疗方法。